Financial Statements — AZN
Balance Sheet
(in billions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Cash & Equivalents | 7.06 | 6.92 | 5.66 | 4.82 | 15.57 |
| Inventory | 6.47 | 5.67 | 5.05 | 6.22 | 4.76 |
| Total Current Assets | 28.94 | 25.39 | 22.84 | 20.92 | 27.27 |
| Goodwill | 21.22 | 21.06 | 19.96 | 19.82 | 11.80 |
| Total Non-current Assets | 83.48 | 78.95 | 73.70 | 75.66 | 46.37 |
| Total Assets | 112.42 | 104.34 | 96.54 | 96.58 | 73.64 |
| Total Current Liabilities | 33.54 | 28.57 | 26.38 | 21.82 | 22.22 |
| Total Non-current Liabilities | 34.08 | 36.18 | 32.75 | 38.81 | 35.73 |
| Total Liabilities | 67.61 | 64.74 | 59.13 | 60.63 | 57.95 |
| Retained Earnings | 7.02 | 1.85 | (0.23) | (1.66) | 5.34 |
| Total Stockholder Equity | 44.81 | 39.60 | 37.42 | 35.95 | 15.69 |
Income Statement
(in billions USD) (except per-share rows)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Total Revenue | 14.46 | 12.94 | 11.42 | 10.77 | 8.22 |
| Cost of Revenue* | 2.47 | 2.18 | 1.96 | 3.00 | 2.19 |
| Gross Profit | 11.98 | 10.76 | 9.46 | 7.77 | 6.03 |
| Research & Development | 3.55 | 3.01 | 2.67 | 2.55 | 1.83 |
| Selling, General & Admin | 4.86 | 4.93 | 4.99 | 4.68 | 3.10 |
| Total Operating Expenses* | 8.48 | 8.01 | 7.00 | 7.23 | 4.90 |
| Operating Income | 3.51 | 2.75 | 2.46 | 0.54 | 1.13 |
| Pretax Income | 3.13 | 2.40 | 2.09 | 0.25 | 0.76 |
| Tax Provision | 0.68 | 0.47 | 0.27 | (0.11) | 0.21 |
| Net Income | 2.45 | 1.93 | 1.82 | 0.36 | 0.55 |
| Basic EPS | 1.58 | 1.24 | 1.17 | 0.23 | 0.84 |
| Diluted EPS | 1.57 | 1.24 | 1.17 | 0.23 | 0.42 |
* Derived from reported values
Cash Flow Statement
(in billions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Operating Cash Flow | 7.10 | 5.57 | 4.85 | 4.48 | 2.83 |
| Investing Cash Flow | (3.36) | (5.28) | (1.77) | (0.97) | 0.32 |
| Financing Cash Flow | (2.19) | 0.81 | (3.55) | (5.03) | 4.56 |
